Osmotica Pharmaceuticals PLC (OQ:OSMT)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for OSMT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 1st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 21/20 Cowan Gregory L Direct Ownership Ordinary Shares F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -11,112 $4.60
May 22/20 May 21/20 Weiss Fred G Direct Ownership Ordinary Shares F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -17,778 $4.60
May 22/20 May 20/20 Cowan Gregory L Direct Ownership Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 38,716  
May 22/20 May 20/20 Weiss Fred G Direct Ownership Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 38,716  
May 22/20 May 20/20 Markison Brian A Direct Ownership Performance-Based Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 249,787  
May 22/20 May 20/20 Markison Brian A Direct Ownership Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 249,787  
May 20/20 May 18/20 Klein Christopher Direct Ownership Performance-Based Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 71,550  
May 20/20 May 18/20 Klein Christopher Direct Ownership Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 71,550  
May 20/20 May 18/20 Einhorn Andrew J. Direct Ownership Performance-Based Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 71,550  
May 20/20 May 18/20 Einhorn Andrew J. Direct Ownership Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 71,550  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for OSMT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 1st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 21/20 Cowan Gregory L Direct Ownership Ordinary Shares F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -11,112 $4.60
May 22/20 May 20/20 Cowan Gregory L Direct Ownership Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 38,716  
May 22/20 May 21/20 Weiss Fred G Direct Ownership Ordinary Shares F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -17,778 $4.60
May 22/20 May 20/20 Weiss Fred G Direct Ownership Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 38,716  
May 22/20 May 20/20 Markison Brian A Direct Ownership Performance-Based Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 249,787  
May 22/20 May 20/20 Markison Brian A Direct Ownership Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 249,787  
May 20/20 May 18/20 Klein Christopher Direct Ownership Performance-Based Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 71,550  
May 20/20 May 18/20 Klein Christopher Direct Ownership Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 71,550  
May 20/20 May 18/20 Einhorn Andrew J. Direct Ownership Performance-Based Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 71,550  
May 20/20 May 18/20 Einhorn Andrew J. Direct Ownership Ordinary Shares A - Grant, award or other under Rule 16b-3(d) 71,550  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $OSMT

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Seattle Genetics (OQ:SGEN)
Alnylam Pharmaceuticals (OQ:ALNY)